Sequence-specific interaction between HIV-1 matrix protein and viral genomic RNA revealed by in vitro genetic selection

RNA. 2001 Apr;7(4):576-84. doi: 10.1017/s1355838201002023.

Abstract

The human immunodeficiency virus type-1 matrix protein (HIV-1 MA) is a multifunctional structural protein synthesized as part of the Pr55 gag polyprotein. We have used in vitro genetic selection to identify an RNA consensus sequence that specifically interacts with MA (Kd = 5 x 10(-7) M). This 13-nt MA binding consensus sequence bears a high degree of homology (77%) to a region (nt 1433-1446) within the POL open reading frame of the HIV-1 genome (consensus sequence from 38 HIV-1 strains). Chemical interference experiments identified the nucleotides within the MA binding consensus sequence involved in direct contact with MA. We further demonstrate that this RNA-protein interaction is mediated through a stretch of basic amino acids within MA. Mutations that disrupt the interaction between MA and its RNA binding site within the HIV-1 genome resulted in a measurable decrease in viral replication.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Base Sequence
  • Binding Sites
  • Consensus Sequence
  • Directed Molecular Evolution
  • Gene Products, gag / metabolism*
  • Gene Products, pol / genetics
  • HIV Antigens / metabolism*
  • HIV-1 / growth & development*
  • Molecular Sequence Data
  • Protein Binding
  • Protein Precursors / metabolism*
  • RNA, Viral / metabolism*
  • RNA-Binding Proteins / metabolism*
  • Sequence Homology, Nucleic Acid
  • T-Lymphocytes / virology
  • Viral Proteins*
  • gag Gene Products, Human Immunodeficiency Virus

Substances

  • Gene Products, gag
  • Gene Products, pol
  • HIV Antigens
  • Protein Precursors
  • RNA, Viral
  • RNA-Binding Proteins
  • Viral Proteins
  • gag Gene Products, Human Immunodeficiency Virus
  • p17 protein, Human Immunodeficiency Virus Type 1
  • p55 gag precursor protein, Human immunodeficiency virus 1